Ardsley Advisory Partners’s Entero Therapeutics ENTO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Hold |
0
| – | -$21K | – | 175 |
|
|
2020
Q3 | – | Hold |
0
| – | -$27K | – | 125 |
|
|
2020
Q2 | – | Hold |
0
| – | -$17K | – | 114 |
|
|
2020
Q1 | – | Hold |
0
| – | -$26K | – | 91 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 126 |
|
|
2019
Q3 | – | Sell |
-1
| Closed | -$255K | – | 167 |
|
|
2019
Q2 | $255K | Hold |
1
| – | – | 0.04% | 106 |
|
|
2019
Q1 | $363K | Hold |
1
| – | – | 0.07% | 85 |
|
|
2018
Q4 | $182K | Hold |
1
| – | – | 0.05% | 83 |
|
|
2018
Q3 | $386K | Hold |
1
| – | – | 0.05% | 101 |
|
|
2018
Q2 | $440K | Hold |
1
| – | – | 0.07% | 103 |
|
|
2018
Q1 | $259K | Hold |
1
| – | – | 0.04% | 118 |
|
|
2017
Q4 | $300K | Buy |
+1
| New | +$300K | 0.04% | 103 |
|
|
2017
Q3 | – | Hold |
0
| – | -$141K | – | 105 |
|
|
2017
Q2 | – | Hold |
0
| – | – | – | 113 |
|